The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Galen Partners Iii L P since 2013.
The trader's CIK number is 1034486.
At the time of the last reporting, Galen Partners Iii L P was the 10% Owner of Acura Pharmaceuticals, Inc. (stock ticker symbol ACUR).
Also see all insider trading activities at Acura Pharmaceuticals, Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | ACUR | 0 | $0 | 2,195,734 | $219,573 | 0 | $0 |
| 2015 | ACUR | 0 | $0 | 275,823 | $219,601 | 0 | $0 |
| 2014 | ACUR | 0 | $0 | 399,979 | $806,635 | 0 | $0 |
| 2013 | ACUR | 0 | $0 | 1,729,737 | $4,129,040 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-12-14 | ACUR | Sale | 2,195,734 | .10 | 219,573 |
| 2015-06-16 | ACUR | Sale | 100,923 | 1.08 | 109,400 |
| 2015-06-17 | ACUR | Sale | 3,900 | 1.05 | 4,095 |
| 2015-01-08 | ACUR | Sale | 100,000 | .60 | 60,200 |
| 2015-01-09 | ACUR | Sale | 36,000 | .65 | 23,436 |
| 2015-01-12 | ACUR | Sale | 35,000 | .64 | 22,470 |
| 2014-03-03 | ACUR | Sale | 2,500 | 2.00 | 5,000 |
| 2014-02-26 | ACUR | Sale | 11,301 | 1.95 | 22,070 |
| 2014-02-27 | ACUR | Sale | 192,479 | 2.04 | 393,042 |
| 2014-02-28 | ACUR | Sale | 147,480 | 2.00 | 295,697 |
| 2014-02-24 | ACUR | Sale | 43,747 | 1.97 | 86,006 |
| 2014-02-21 | ACUR | Sale | 272 | 1.95 | 530 |
| 2014-02-18 | ACUR | Sale | 2,200 | 1.95 | 4,290 |
| 2013-10-10 | ACUR | Sale | 4,200 | 2.05 | 8,610 |
| 2013-07-02 | ACUR | Sale | 200,000 | 2.15 | 430,000 |
| 2013-06-17 | ACUR | Sale | 20,446 | 2.15 | 43,958 |
| 2013-06-12 | ACUR | Sale | 3,469 | 2.20 | 7,631 |
| 2013-06-14 | ACUR | Sale | 27,814 | 2.15 | 59,800 |
| 2013-06-10 | ACUR | Sale | 9,700 | 2.21 | 21,437 |
| 2013-06-07 | ACUR | Sale | 11,796 | 2.19 | 25,833 |
| 2013-06-04 | ACUR | Sale | 22,802 | 2.21 | 50,392 |
| 2013-06-05 | ACUR | Sale | 6,650 | 2.21 | 14,696 |
| 2013-06-06 | ACUR | Sale | 10,001 | 2.13 | 21,302 |
| 2013-05-30 | ACUR | Sale | 12,860 | 2.26 | 29,012 |
| 2013-05-31 | ACUR | Sale | 18,699 | 2.25 | 42,072 |
| 2013-05-21 | ACUR | Sale | 47,410 | 2.30 | 108,995 |
| 2013-05-16 | ACUR | Sale | 42,599 | 2.21 | 94,101 |
| 2013-05-17 | ACUR | Sale | 54,460 | 2.36 | 128,307 |
| 2013-05-20 | ACUR | Sale | 68,993 | 2.40 | 165,238 |
| 2013-05-14 | ACUR | Sale | 87,399 | 2.44 | 213,253 |
| 2013-05-15 | ACUR | Sale | 23,585 | 2.27 | 53,608 |
| 2013-05-13 | ACUR | Sale | 72,450 | 2.21 | 160,042 |
| 2013-05-03 | ACUR | Sale | 27,117 | 2.26 | 61,257 |
| 2013-05-06 | ACUR | Sale | 105,300 | 2.12 | 223,551 |
| 2013-05-07 | ACUR | Sale | 20,887 | 2.23 | 46,640 |
| 2013-05-02 | ACUR | Sale | 49,937 | 2.47 | 123,344 |
| 2013-04-30 | ACUR | Sale | 18,794 | 2.48 | 46,571 |
| 2013-05-01 | ACUR | Sale | 106,027 | 2.37 | 251,708 |
| 2013-04-29 | ACUR | Sale | 13,642 | 2.56 | 34,896 |
| 2013-04-25 | ACUR | Sale | 16,700 | 2.67 | 44,555 |
| 2013-04-26 | ACUR | Sale | 26,000 | 2.56 | 66,430 |
| 2013-04-17 | ACUR | Sale | 238,756 | 3.20 | 764,974 |
| 2013-04-12 | ACUR | Sale | 13,200 | 2.22 | 29,317 |
| 2013-04-16 | ACUR | Sale | 21,800 | 2.11 | 45,932 |
| 2013-04-15 | ACUR | Sale | 4,303 | 2.10 | 9,023 |
| 2013-04-10 | ACUR | Sale | 25,118 | 2.17 | 54,380 |
| 2013-04-11 | ACUR | Sale | 96,336 | 2.24 | 215,985 |
| 2013-04-05 | ACUR | Sale | 99,933 | 2.16 | 215,555 |
| 2013-04-08 | ACUR | Sale | 80,554 | 2.16 | 173,835 |
| 2013-04-09 | ACUR | Sale | 20,000 | 2.14 | 42,800 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Galen Partners Iii L P (10% Owner of Acura Pharmaceuticals, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.